Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
23.64%Operating Cash Flow Margin
VS
Market
Sector
Industry
History
$ 13.83Close
$ 9.55 - $ 70 52-Week Range
Ticker Information
Ticker
KROSCompany Name
KEROS THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQKEROS THERAPEUTICS INC - Operating Cash Flow Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
KROS - OCF % Historical data
| Date | Net Cash Flow - Operations | Operating Cash Flow Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 55.04M | 23.64% | $ 232.84M |
| 3/31/2025 | $ 44.86M | 20.89% | $ 214.71M |
| 12/31/2024 | $ -160.87M | -4531.52% | $ 3.55M |
| 9/30/2024 | $ -140.32M | -21554.53% | $ 651K |
| 6/30/2024 | $ -143.8M | -53063.47% | $ 271K |
| 3/31/2024 | $ -134.83M | -57620.94% | $ 234K |
| 12/31/2023 | $ -124.51M | -82455.63% | $ 151K |
| 9/30/2023 | $ -120.49M | -1506150% | $ 8K |
| 6/30/2023 | $ -111.11M | 0% | $ 0 |
| 3/31/2023 | $ -102.87M | 0% | $ 0 |
Key Performance Insights, Last 5 Years
- KEROS THERAPEUTICS INC's latest trailing twelve months (TTM) OCF % stands at 0%.
- Over the past 5 years, KEROS THERAPEUTICS INC's average OCF % has been -130292.77%.
- The median OCF % for KEROS THERAPEUTICS INC during this period was -13043.03%
- KEROS THERAPEUTICS INC reached its highest OCF % over the past 5 years at 23.64%.
- The lowest OCF % recorded by KEROS THERAPEUTICS INC in the same timeframe -1506150%
KEROS THERAPEUTICS INC's OCF % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
OCF % Benchmarks
Similar metrics to Revenues:
- Operating Margin - [Calculation] A company’s operating income [OpInc] as a percentage of [Revenue]. The operating margin measures how much profit a company produces for each dollar of revenue generated, after paying for variable costs such as wages and raw materials.
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
- Depreciation and Amortization Margin - [Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].
Definition of Operating Cash Flow Margin
[Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].CF - Operations / Revenues
(=) OCF % OCF % for KEROS THERAPEUTICS INC is calculated as follows: CF - Operations [ $ -36.89M ] / Revenues [ $ 0 ]
(=) OCF % [ 0% ] KROS - Operating Cash Flow Margin, Last 5 years
-1506150%
Minimum
Sep 30, 2023
23.64%
Maximum
Jun 30, 2025
-130292.77%
Average
-13043.03%
Median
OCF % Benchmark AnalysisMarket
The chart above depicts the distribution of OCF % for companies in the Total Stock Market. The average OCF % of the companies is 14.31% with a standard deviation of 21.13%.
The following table provides additional summary stats:
OCF % in the Market:
| filtered constituents | 3.25K |
|---|---|
| min | -57.27% |
| max | 77.08% |
| average | 14.31% |
| median | 12.65% |
| std | 21.13% |